Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion type Assertion NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_head.
- NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion wasGeneratedBy ECO_0000203 NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_provenance.
- NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion wasDerivedFrom befree-20140225 NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_provenance.
- NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion SIO_000772 16458962 NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_provenance.
- NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion evidence source_evidence_literature NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_provenance.
- NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_assertion description "[Defects in the tumour suppressor gene p53 pathway are known to be important in CLL and p53 inactivation is associated with a particularly aggressive form of CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226557.RA4ebxzxgKePucrOqueQqz6DpwJQSirA6O7diy7WEz4Yc130_provenance.